Publication | Closed Access

A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: Consistent chromosomal abnormalities and temporary C-MYC gene amplification

Hematological MalignancyChromatinEssential ThrombocythemiaMixed-phenotype Acute LeukemiaGeneticsMalignant Blood DisorderHematologyConsistent Chromosomal AbnormalitiesMedicineCell BiologyMyeloid Neoplasia